Skip to main navigation Skip to search Skip to main content

Myostatin inhibition in combination with antisense oligonucleotide therapy improves outcomes in spinal muscular atrophy

  • Haiyan Zhou
  • , Jinhong Meng
  • , Alberto Malerba
  • , Francesco Catapano
  • , Palittiya Sintusek
  • , Susan Jarmin
  • , Lucy Feng
  • , Ngoc Lu-Nguyen
  • , Lianwen Sun
  • , Virginie Mariot
  • , Julie Dumonceaux
  • , Jennifer E. Morgan
  • , Paul Gissen
  • , George Dickson
  • , Francesco Muntoni

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)768-782
Number of pages15
JournalJournal of Cachexia, Sarcopenia and Muscle
Volume11
Issue number3
Early online date7 Feb 2020
DOIs
Publication statusPublished - Jun 2020

Keywords

  • Adeno-associated virus
  • Antisense oligonucleotide
  • Combinatorial therapy
  • Myostatin inhibition
  • Myostatin propeptide
  • Spinal muscular atrophy
  • Survival of motor neuron 1 gene

Cite this